OS THERAPIES INCORPORATED Amortization
OS THERAPIES INCORPORATED (OSTX) reported Amortization of $124.24 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2026-05-18
- OS THERAPIES INCORPORATED amortization for the quarter ending 2026-03-31 was $124.24K.
- OS THERAPIES INCORPORATED amortization for the quarter ending 2025-03-31 was $0.00.
- OS THERAPIES INCORPORATED amortization for the quarter ending 2024-12-31 was -$1.43M.
- OS THERAPIES INCORPORATED amortization for the quarter ending 2024-09-30 was $338.29K.
- OS THERAPIES INCORPORATED amortization for fiscal 2025 was $360.31K.
- OS THERAPIES INCORPORATED amortization for fiscal 2024 was $0.00.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2026-03-31 | $124.24K 10-Q · filed 2026-05-18 | |||
| 2025-12-31 | $360.31K 10-K · filed 2026-03-31 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-18 | -$1.43M derived: sum of 2 quarters · filed 2026-05-18 | -$1.09M derived: sum of 3 quarters · filed 2026-05-18 | |
| 2024-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.09M derived: sum of 2 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 | |
| 2024-09-30 | $338.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.43M 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $1.09M 10-Q · filed 2025-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |